Identification of a novel tumor necrosis factor α-responsive region in the NCF2 promoter

被引:11
作者
Gauss, KA [1 ]
Bunger, PL [1 ]
Larson, TC [1 ]
Young, CJ [1 ]
Nelson-Overton, LK [1 ]
Siemsen, DW [1 ]
Quinn, MT [1 ]
机构
[1] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA
关键词
neutrophil; promoter; transcriptional regulation; NADPH oxidase; monocyte;
D O I
10.1189/jlb.0604329
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The phagocyte reduced nicotinamide adenine dinucleotide phosphate oxidase is a multiprotein enzyme that catalyzes the production of microbicidal oxidants. Although oxidase assembly involves association of several membrane and cytosolic oxidase proteins, one of the cytosolic cofactors, p67(phox), appears to play a more prominent role in final activation of the enzyme complex. Based on the importance of p67(phox), we investigated transcriptional regulation of the p67(phox) gene [neutrophil cytosolic factor 2 (NCF2)] and demonstrated previously that activator protein-1 (AP-1) was essential for basal transcriptional activity. As p67(phox) can be up-regulated by tumor necrosis factor alpha (TNF-alpha), which activates AP-1, we hypothesized that TNF-alpha might regulate NCF2 transcription via AP-1. In support of this hypothesis, we show here that NCF2 promoter-reporter constructs are up-regulated by TNF-alpha but only when AP-1 factors were coexpressed. Consistent with this observation, we also demonstrate that NCF2 mRNA and p67(phox) protein are up-regulated by TNF-alpha in various myeloid cell lines as well as in human monocytes. It was surprising that mutagenesis of the AP-1 site in NCF2 promoter constructs did not eliminate TNF-alpha induction, suggesting additional elements were involved in this response and that AP-1 might play a more indirect role. Indeed, we used NCF2 promoter-deletion constructs to map a novel TNF-alpha-responsive region (TRR) located between -56 and -16 bp upstream of the translational start site and demonstrated its importance in vivo using transcription factor decoy analysis. Furthermore, DNase footprinting verified specific binding of factor(s) to the TRR with AP-1 binding indirectly to this region. Thus, we have identified a novel NCF2 promoter/enhancer domain, which is essential for TNF-alpha-induced up-regulation of p67(phox).
引用
收藏
页码:267 / 278
页数:12
相关论文
共 72 条
[1]   Activation of the superoxide-generating NADPH oxidase by chimeric proteins consisting of segments of the cytosolic component p67phox and the small GTPase Rac1 [J].
Alloul, N ;
Gorzalczany, Y ;
Itan, M ;
Sigal, N ;
Pick, E .
BIOCHEMISTRY, 2001, 40 (48) :14557-14566
[2]   NADPH oxidase [J].
Babior, BM .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) :42-47
[3]   Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: critical role of NADPH oxidase [J].
Barbieri, SS ;
Eligini, S ;
Brambilla, M ;
Tremoli, E ;
Colli, S .
CARDIOVASCULAR RESEARCH, 2003, 60 (01) :187-197
[4]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[5]   Signal transduction by tumor necrosis factor and its relatives [J].
Baud, V ;
Karin, M .
TRENDS IN CELL BIOLOGY, 2001, 11 (09) :372-377
[6]   c-Jun is a JNK-independent coactivator of the PU.1 transcription factor [J].
Behre, G ;
Whitmarsh, AJ ;
Coghlan, MP ;
Hoang, T ;
Carpenter, CL ;
Zhang, DE ;
Davis, RJ ;
Tenen, DG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :4939-4946
[7]   Current molecular models for NADPH oxidase regulation by Rac GTPase [J].
Bokoch, GM ;
Diebold, BA .
BLOOD, 2002, 100 (08) :2692-2696
[8]   The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction [J].
Burger, Danielle ;
Dayer, Jean-Michel .
ARTHRITIS RESEARCH & THERAPY, 2002, 4 (Suppl 3) :S169-S176
[9]   Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages - Contributions to atherosclerosis [J].
Cathcart, MK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (01) :23-28
[10]  
CATHCART MK, 1989, J IMMUNOL, V142, P1963